The Cerebellum Plays a Protective Role in Cognitive Aging and Disease: Insights from a Multi‐Cohort Study

Federico d’Oleire Uquillas, Esra Sefik, Jakob Seidlitz, Jewel Merriman, Veronica Zhang, Mikhail Kislin, Jonathan D. Cohen, Aaron Alexander‐Bloch, Richard A. I. Bethlehem, Jorge Sepulcre, Samuel S.‐h. Wang, Patrizia Vannini, Jesse Gomez, the Alzheimer's Disease Neuroimaging InitiativeAlzheimer 2024 · DOI

TL;DR

This study reveals that the cerebellum, particularly its posterior regions, plays a significant protective role against age-related cognitive decline. Larger cerebellar volumes are associated with better cognitive function and slower decline, even in the presence of Alzheimer's disease pathology, suggesting the cerebellum is a key component of brain reserve.

What Problem Does This Paper Address?

Understanding "brain reserve" – the brain's ability to withstand or compensate for age-related changes or damage – is crucial for developing strategies to combat cognitive decline and neurodegenerative diseases like Alzheimer's. While much research has focused on the neocortex, the cerebellum, a large brain structure traditionally associated with motor control, has been historically understudied in the context of cognitive aging and reserve. This paper aims to fill that gap by investigating the cerebellum's role in cognitive resilience across multiple large-scale aging cohorts.

Methods

The researchers employed a multi-cohort, cross-sectional and longitudinal analysis approach. They used advanced neuroimaging techniques to analyze cerebellar tissue volume and its association with cognitive performance (measured by the Montreal Cognitive Assessment - MOCA), age, amyloid-beta burden, and APOE genotype. Statistical models controlled for covariates like sex, estimated intracranial volume, and household income. Spatial analysis was used to pinpoint specific cerebellar regions most affected by aging and most strongly correlated with cognitive scores.

Datasets

The study utilized data from three major, well-established aging cohorts:

  • Human Connectome Project-Aging (HCP-Aging): 708 participants aged 36-100 years.
  • UK Biobank: 45,013 participants aged 44-81 years.
  • Alzheimer's Disease Neuroimaging Initiative (ADNI): 1,441 participants aged 56-95 years, including individuals who were cognitively normal, had mild cognitive impairment, or Alzheimer's disease dementia.

These datasets represent a significant aggregation of aging brain data, allowing for robust statistical analysis and validation of findings across different populations and study designs.

Key Insights and Ideas

  • Cerebellum as a Cognitive Reserve Hub: The cerebellum is not just for motor control; it's a significant player in cognitive reserve, offering protection against age-related cognitive decline.
  • Posterior Cerebellum is Key: Aging effects are not uniform across the cerebellum. The posterior regions (specifically Crus I) show the most pronounced aging-related changes and are most strongly linked to cognitive function.
  • Cerebellar Volume is Protective: Individuals with larger cerebellar volumes exhibit better cognitive performance (MOCA scores) and slower cognitive decline, even in the early stages of Alzheimer's disease.
  • Protection Persists Until Significant Pathology: The protective effect of the cerebellum holds up even in the presence of amyloid-beta pathology, though this protection may be diminished in individuals with high amyloid burden and the APOE ε4/ε4 genotype.
  • Cerebellum-Neocortex Interaction: The association between cerebellar tissue density and MOCA scores is as strong as that observed in the neocortex, highlighting a significant interplay between these brain regions in maintaining cognitive function.

Key Results

  • Aging Gradient: Spatial analysis of HCP-Aging data showed that posterior cerebellar regions (Crus I) were more affected by aging than anterior regions (Lobule I-III) (p < 0.05, Bonferroni-corrected). This was validated in the UK Biobank (p < 0.0001).
  • Cognitive Association: MOCA scores were strongly associated with higher cerebellar tissue density (p < 0.0001), particularly in posterior cerebellar cortex, which overlaps with key cognitive networks (frontoparietal, ventral attention, default mode).
  • Protective Effect: Greater volume in this MOCA-related cerebellar cortex signature protected against aging-related cognitive decline (p = 0.029). In the UK Biobank, larger cerebellar volumes were linked to less decline in processing speed and executive function (Trails Making-B: p = 0.001; Digit Symbol Substitution: p = 0.038).
  • ADNI Findings: In ADNI, AD patients with low amyloid-beta burden (Aβ-) showed the strongest cerebellar association with MOCA (volume x group, Aβ- AD: p = 0.00004). The APOE genotype interacted with cerebellar volume on MOCA in Aβ- individuals, with ε4/ε4 carriers showing the most pronounced effect (volume x APOE, ε4/ε4: p = 0.017).

Limitations and Future Work

Limitations: * The study acknowledges that the protective effect of the cerebellum may be attenuated in the presence of significant amyloid burden, particularly in APOE ε4/ε4 carriers. * While household income was considered, it's a proxy for socioeconomic status and may not fully capture all factors contributing to brain reserve.

Future Work: * The authors suggest that the cerebellum's integral contribution to brain reserve has substantial implications for aging populations and should be a focus of future clinical research. * Further investigation into the specific mechanisms by which the cerebellum contributes to cognitive reserve and how this interaction is modulated by genetic factors (like APOE) and pathological burden (like amyloid-beta) is warranted. * Exploring therapeutic strategies that target or leverage cerebellar function for cognitive enhancement or neuroprotection could be a promising avenue.

Summary updated

Abstract

Abstract Background Studying brain reserve — the brain’s resilience to age‐related changes or damage — is crucial for understanding protective mechanisms against cognitive decline. The cerebellum may be a key region in brain reserve, but it has been historically understudied. This investigation delves into this critical area within the largest aging multi‐cohort to date. Methods Data were sourced from the Human Connectome Project‐Aging (n=708, 36‐100yrs), UK Biobank (n=45,013, 44‐81yrs), and ADNI (n=1,441, 56‐95yrs). ADNI participants were cognitively normal, had mild cognitive impairment, or Alzheimer’s disease (AD) dementia. We examined associations between cerebellar tissue volume, age, Montreal Cognitive Assessment (MOCA) scores, global PET amyloid burden, and APOE genotype. Statistical models included sex and estimated intracranial volume (eTIV) as covariates, with adjusted household income considered when available. Results Spatial analysis of HCP‐Aging data revealed that aging unfolds heterogeneously across the cerebellum; posterior portions of the cerebellum (Crus I) showed greater effects than anterior regions (Lobule I‐III) (Bonferroni‐corrected, p&lt;0.05). MOCA scores were associated with higher tissue density in the cerebellum (p&lt;0.0001), as much as neocortex, and MOCA scores coupled most strongly with posterior cerebellar cortex, overlapping frontoparietal, ventral attention, and default mode network representations. Strikingly, greater volume in this MOCA‐related cerebellar cortex signature protected against aging‐related cognitive decline (p=0.029). We validate tissue aging results in the UK Biobank – again, posterior cerebellum demonstrated the greatest aging effect (p&lt;0.0001), and individuals with greater cerebellar volumes showed less decline in processing speed and executive function (Trails Making‐B time: p=0.001; Digit Symbol Substitution score: p=0.038). Across all ADNI diagnostic groups, AD patients with low amyloid‐beta burden (Aβ‐) exhibited the strongest cerebellar association with MOCA (volume x group, Aβ‐ AD: p=0.00004). In Aβ‐ individuals, APOE genotype interacted with cerebellar volume on MOCA, with ε4/ε4 carriers showing the greatest effect (volume x APOE, ε4/ε4: p=0.017). Conclusions Our large‐scale study demonstrates the cerebellum’s critical role in mitigating patterns of cognitive decline. This protection persists until significant amyloid burden, especially in APOE ε4/ε4 carriers, reshaping our understanding of reserve and AD risk. The cerebellum’s integral contribution to brain reserve has substantial implications for aging populations and should be a focus of future clinical research.
BibTeX
@inproceedings{uquillas2024cerebellum,
  author = {Federico d’Oleire Uquillas and Esra Sefik and Jakob Seidlitz and Jewel Merriman and Veronica Zhang and Mikhail Kislin and Jonathan D. Cohen and Aaron Alexander‐Bloch and Richard A. I. Bethlehem and Jorge Sepulcre and Samuel S.‐H. Wang and Patrizia Vannini and Jesse Gomez and the Alzheimer's Disease Neuroimaging Initiative},
  title = {{The Cerebellum Plays a Protective Role in Cognitive Aging and Disease: Insights from a Multi‐Cohort Study}},
  booktitle = {Alzheimer},
  year = {2024},
  doi = {10.1002/alz.085743},
}
Figure